Golden Independence Mining CEO Jeremy Poirier joined Steve Darling from Proactive to share news the company has released a strong independent Preliminary Economic Assessment on the company’s Independence project in Nevada.

Poirier sharing the numbers including after-tax NPVof 35 million with an IRR of 18% with a 1,700/oz gold and 24.00/oz silver price. Significant leverage to metal prices with after-tax NPV5% of US$45M and IRR of 22% at spot prices. Initial Capital of US$63 million including working capital and contingencies. The Mine life of 6.1 years using only 60% of the near surface resource.

Revolve Renewable Power CEO Steve Dalton and President Omar Bojorquez joined Steve Darling from Proactive to share news the company has officially started trading on the TSX-Venture under the ticker “REVV”

Dalton tells Proactive more about the origins of the company and the fact they are now public.

Bojorquez shares with Proactive more about the opportunity as they look to help the world move towards renewable technology including wind and solar.

Superloop Limited's Paul Tyler speaks with Proactive during the ASX Small and Mid-Cap Conference, March 2022.

The company's purpose is to enable better internet for Australian homes and businesses by allowing challenger retail brands - including its own Superloop and Exetel brands - to take a larger share of the market, leveraging Superloop's Infrastructure-on-Demand platform.

Peter Warren Automotive's Mark Weaver speaks with Proactive during the ASX Small and Mid-Cap Conference, March 2022.

The company's an automotive dealership group that's been operating in Australia for over 60 years. It operates 82 franchise operations and represents 28 OEMs.

SILK Laser Australia's Martin Perelman speaks with Proactive during the ASX Small and Mid-Cap Conference, March 2022.

SILK is one of Australia’s largest specialist clinic networks, offering a range of nonsurgical aesthetic products and services. Its five core offerings comprise laser hair removal, cosmetic injectables, skin treatments, body contouring and skincare products.

Atomo Diagnostics Ltd's John Kelly speaks with Proactive during the ASX Small and Mid-Cap Conference. It's an Australian medical device company supplying unique, integrated rapid diagnostic test (RDT) devices to the global diagnostic market.

Next Science Limited's Judith Mitchell speaks with Proactive during the ASX Small and Mid-Cap Conference. The company's primary focus is on the development and continued commercialisation of its proprietary XBIO technology to reduce the impact of biofilm based infections in human health.

EBR Systems' John McCutcheon speaks with Proactive during the ASX Small and Mid-Cap Conference. The company's focused on the treatment of cardiac rhythm disease by providing more

physiologically effective stimulation through wireless cardiac pacing. Its Wireless Stimulation Endocardially (WiSE) technology was developed to eliminate the need for cardiac pacing leads.

Race Oncology Ltd's Phillip Lynch speaks with Proactive during the ASX Small and Mid-Cap Conference. They're a precision oncology company with a cancer drug called Zantrene®. It's a potent inhibitor of the Fatso/Fat mass and obesity associated (FTO) protein. Overexpression of FTO has been shown to be the genetic driver of a diverse range of cancers.

Opthea Limited's Megan Baldwin speaks with Proactive during the ASX Small and Mid-Cap Conference, March 2022.

It's a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases.